Belinostat and panobinostat (HDACI): In vitro and in vivo studies in thyroid cancer

by Chan, D., Zheng, Y., Tyner, J.W., Chng, W.J., Chien, W.W., Gery, S., Leong, G., Braunstein, G.D., Koeffler, H.P.
Published 2014

Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivo

by Chan, D., Tyner, J.W., Chng, W.J., Bi, C., Okamoto, R., Said, J., Ngan, B.D., Braunstein, G.D., Koeffler, H.P.
Published 2016

Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets

by Kanojia, D, Garg, M, Martinez, J, Anand, M.T, Luty, S.B, Doan, N.B, Said, J.W, Forscher, C, Tyner, J.W, Koeffler, H.P
Published 2020

Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations

by Lim, S.L., Damnernsawad, A., Shyamsunder, P., Chng, W.J., Han, B.C., Xu, L., Pan, J., Pravin, D.P., Alkan, S., Tyner, J.W., Koeffler, H.P.
Published 2021

Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3

by Chien W., Sun Q.-Y., Ding L.-W., Wuensche P., Torres-Fernandez L.A., Tan S.Z., Tokatly I., Zaiden N., Poellinger L., Mori S., Yang H., Tyner J.W., Koeffler H.P., Sethi, Gautam.
Published 2016

Identification of a novel SYK/c-MYC/MALAT1 signaling pathway and its potential therapeutic value in Ewing sarcoma

by Sun, H, Lin, D.-C, Cao, Q, Pang, B, Gae, D.D, Lee, V.K.M, Lim, H.J, Doan, N, Said, J.W, Gery, S, Chow, M, Mayakonda, A, Forscher, C, Tyner, J.W, Koeffler, H.P
Published 2020

Genomic landscape of liposarcoma

by Kanojia, D, Nagata, Y, Garg, M, Lee, D.H, Sato, A, Yoshida, K, Sato, Y, Sanada, M, Mayakonda, A, Bartenhagen, C, Klein, H.-U, Doan, N.B, Said, J.W, Mohith, S, Gunasekar, S, Shiraishi, Y, Chiba, K, Tanaka, H, Miyano, S, Myklebost, O, Yang, H, Dugas, M, Meza-Zepeda, L.A, Silberman, A.W, Forscher, C, Tyner, J.W, Ogawa, S, Phillip Koeffler, H
Published 2020